Research Article
Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis
Figure 1
Lesion progression (lesion size: mm2) observed during treatment and follow-up periods in Shiunko and placebo groups. The rate of lesion reduction during treatment period in the Shiunko group was significantly higher than placebo group (Wilcoxon Signed Rank test, ).